Ashland Inc. launched Permexa sodium caprate, an intestinal permeation enhancer for oral peptide and biologic drugs such as GLP-1 agonists. This excipient aims to improve formulation consistency and s
Ashland has launched permexa™ sodium caprate, an intestinal permeation enhancer designed to facilitate the oral delivery of peptides and biologics such as GLP-1 agonists. This excipient aims to improv
Ashland Inc. received a Moderate Buy consensus from twelve brokerages with a $73.90 average price target, supported by high institutional ownership and a quarterly dividend.
Massachusetts Financial Services filed an amended Schedule 13G disclosing a 4.5% beneficial ownership stake in Ashland Inc., holding over 2 million shares as of June 30, 2026.
Omega Advisors increased its stake in specialty materials firm Ashland Inc by 1.215 million shares, though analyst models suggest the stock remains 9% overvalued despite strong financial health scores
Ashland Inc. has announced updates to its Board of Directors' committee assignments for new directors Allen A. Spizzo and Peter T. Thomas, effective August 7, 2026.
An analyst suggests Ashland Global Holdings Inc., a chemicals maker, could be valued at $90 per share in a potential takeover. The company is considering a sale following received takeover interest.
Ashland Global Holdings Inc. announced a quarterly dividend and established a Capital Allocation Advisory Committee following an agreement with Ancora Holdings Group. These changes aim to influence in
Ashland Global Holdings Inc declared a quarterly cash dividend of $0.42 per share, payable on September 15, 2026, to shareholders of record as of September 1, 2026.
Ashland Global Holdings Inc declared a quarterly cash dividend of $0.42 per share, payable on September 15, 2026. Stockholders of record as of September 1, 2026, will receive the payment.
Ashland Inc. shares rose 6% after reports emerged that the chemical maker is exploring a potential sale. The company has engaged Citigroup and Lazard to solicit offers from strategic and private equit
Analysts raised Ashland Inc.'s average 12-month price target to $79.91, implying 11% upside, with a consensus Buy rating from 12 analysts.
Ashland Inc. director Allen A. Spizzo filed an initial Form 3 to register insider status, with no equity transactions reported in the filing.
Ashland Global Holdings Inc. (MUN:AHT) displays its forward price-to-earnings ratio on the Munich Stock Exchange, where the market is currently closed with no trades recorded. Data is provided via Tra
Omega Capital Partners reported a 6.4% beneficial ownership stake in Ashland Inc., totaling 2.9 million shares via a Schedule 13G filing indicating a passive investment position.
A law firm is investigating Ashland Inc. after Q2 2026 results missed estimates due to operational challenges at its Hopewell manufacturing facility, causing a stock price drop.
Bronstein, Gewirtz & Grossman, LLC is investigating Ashland Inc. after Q2 2026 financial results missed estimates and operational challenges at its Hopewell facility impacted guidance.
Ashland Global Holdings reported Q3 2026 adjusted EPS of $1.02 with $103 million in free cash flow, despite a mild stock pullback. Market analysts assess if this cash generation addresses lingering ma
Ashland Global Holdings extended its $70 million receivables securitization facility with PNC Bank until July 2028 to maintain liquidity through a bankruptcy-remote special purpose entity.
Ashland Inc. reported Q3 2026 earnings with an EPS of $1.02 and revenue of $497 million, exceeding analyst estimates despite a 7.34% year-over-year revenue decline.
TradingView displays the enterprise value to forward revenue metric for Ashland Inc. (SWB:AHT), though the page currently lacks specific financial data or analysis.
Vanguard Portfolio Management LLC disclosed a 5.42% stake in Ashland Inc via Schedule 13G, holding 2.48 million shares as of June 30, 2026.
Ashland Inc.'s SVP and CTO Osama M. Musa exercised 9,793 Stock Appreciation Rights under a Rule 10b5-1 plan, acquiring 1,267 common shares at $57.96 per share.
Ashland Inc. reported Q3 2026 revenue of $497 million, up 7.3% year-over-year, driven by Life Sciences and Personal Care segments. The company also noted progress in its manufacturing network optimiza
Ashland Global Holdings Inc. Senior Vice President Alessandra Faccin converted 3,215 RSUs to common stock on July 27, 2026, withholding shares for taxes. Her direct equity award balance totaled 9,646
Ashland Global Holdings Inc reached a settlement with activist investor Ancora, although detailed terms were not disclosed in the report.
Eleven analysts raised their average 12-month price target for Ashland Inc. stock to $71.91, implying a 6% upside. The consensus rating remains Buy among 12 analysts, signaling positive market sentime
Ashland Global Holdings reported Q3 2026 revenue of $497 million, exceeding consensus estimates despite slightly lower EPS. Strong performance in Life Sciences and Intermediates segments drove stock o
Ashland Global Holdings Inc has reported its earnings for the quarter ending June 30. Complete details regarding the financial results are available through external sources like Reuters and TradingVi
Ashland Global Holdings settled with activist investor Ancora Holdings, adding two independent directors and forming a capital allocation committee to address shareholder concerns and potentially purs
Ashland Global Holdings Inc appointed Peter Thomas and Allen Spizzo to its Board of Directors under a cooperation agreement with Ancora Holdings Group, establishing a Capital Allocation Advisory Commi
Chemical maker Ashland Global Holdings has reached a settlement with activist investor Ancora Holdings, resulting in two new board appointments and plans to reduce the board size next year.
Franklin Resources disclosed a 7.9% beneficial ownership stake in Ashland Global Holdings Inc., aggregating holdings from its investment management subsidiaries as of March 31, 2026.
Ashland Global Holdings Inc. is set to report Q3 earnings amidst pressure from activist investors pushing for a strategic sale. Investors will watch segment performance and management's response to po
Ashland Global Holdings reported a fiscal Q3 net income of $16 million, beating prior losses, while revenue hit $497 million against forecasts. Full-year guidance stands at $1.84–1.87 billion, contrib
Wolfe Research raised Ashland's price target to $78 with an Outperform rating, citing anticipated activism and strategic discussions despite operational challenges.
Ashland Inc. shares closed at $66.40, down 0.22%, with analysts maintaining a "Buy" rating and a target price of $69.12. The company is deemed fairly valued within the Chemicals industry despite recen
Ashland Global Holdings Inc details key metrics for its 6.875% bond maturing in 2043, including outstanding amount and coupon rate. The profile outlines business segments such as Life Sciences, Person
Ashland Global Holdings reported Q1 revenue of $611 million and EBITDA of $131 million, driven by its specialty additives and ingredients portfolio. Strong profitability metrics support the company's
Ashland Global Holdings stock reached a 52-week high of $68.32, marking a 33% annual increase. Activist investor Ancora Holdings Group is pushing for a sale with a potential 33% premium.
Ashland reported Q2 2026 sales of $482 million, up 1% driven by Personal Care and Life Sciences. Full-year guidance was updated to $1.835–$1.87 billion, though net income and adjusted EBITDA declined
Ashland Global Holdings Inc announced its Q3FY26 earnings release date as July 28, 2026, with a subsequent webcast featuring senior executives to discuss financial performance.
Ashland Global Holdings Inc scheduled its Q3 fiscal 2026 earnings release for July 28, followed by an analyst webcast on July 29 featuring key executives including CEO Guillermo Novo.
Ashland Global Holdings Inc. scheduled its Q3 fiscal 2026 earnings release for July 28, 2026. A live analyst webcast featuring key executives will follow on July 29.
Ashland Inc. (FWB:AHT) financial data on the Frankfurt Stock Exchange displays its enterprise value to revenue forward ratio, accessible via TradingView platform features.
Ashland Global Holdings Inc stock remains steady as the company focuses on specialty chemistries and formulated ingredients for industrial and consumer markets. Investors are advised to monitor the bu
Ashland Global Holdings Inc. financial metrics are tracked on the Lang & Schwarz Exchange via TradingView. The page displays enterprise value to EBIT forward data without active trading.
Ashland Inc. financial data on TradingView displays the Price to Book Forward metric, showing a closed market status with no current trades.
BlackRock Inc. filed an amended Schedule 13G/A disclosing a 12.3% beneficial ownership stake in Ashland Inc., totaling 5.64 million shares. This filing confirms sole voting power over the holdings wit
Ashland Inc published its latest SEC filings, outlining financial performance, valuation metrics, and stock data including earnings per share and ownership figures.
ChemBrief